PROC

Oncology·MeSH: Endometrial Neoplasms

55 drugs in development·34 companies·2 clinical trials

Drug Pipeline by Phase

Approved(28)

Drug	Company
AMNIOCORD	MiMedx Group Inc (MDXG)
AMNIOEFFECT	MiMedx Group Inc (MDXG)
Arestin	Bausch Health Companies Inc. (BHC)
bupivacaine	Spero Therapeutics, Inc. (SPRO)
CellFX Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
dexmedetomidine	Mylan II B.V. (MYL)
doptelet	AKORN INC (AKRX)
dysport	NEXIEN BIOPHARMA, INC. (NXEN)
EPICORD	MiMedx Group Inc (MDXG)
Follistim AQ	Organon & Co. (OGN)
gel-one cross-linked hyaluronate	Zimmer Biomet Holdings Inc. (ZBH)
grafixpl prime	OSIRIS THERAPEUTICS, INC. (OSIR)
liberty endovascular robotic surgical system	Microbot Medical Inc. (MBOT)
lidocaine	ANTHERA PHARMACEUTICALS INC (ANTH)
lidocaine	MANNKIND CORP (MNKD)
lymphoseek kit	Cardinal Health Inc. (CAH)
metronidazole in plastic container	Amneal Pharmaceuticals, Inc. (AMRX)
nPulse Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
nsPFA Percutaneous Electrode System	Pulse Biosciences Inc Common Stock (DE) (PLSE)
pravastatin	Aptinyx Inc. (APTX)
PrepaCyte CB Processing System	Cryo-Cell International Inc. (CCEL)
PrepaCyte® CB Processing System	Cryo-Cell International Inc. (CCEL)
procainamide	NEXUS BIOPHARMA INC (NEXS)
prochlorperazine edisylate	NEXUS BIOPHARMA INC (NEXS)
TechneLite	Lantheus Holdings, Inc. (LNTH)
tirofiban	NEXUS BIOPHARMA INC (NEXS)
Vybrance Percutaneous Electrode System	Pulse Biosciences Inc Common Stock (DE) (PLSE)
zokinvy	Eiger BioPharmaceuticals, Inc. (EIGR)

Phase 3(4)

Drug	Company
bentracimab	PhaseBio Pharmaceuticals Inc (PHAS)
melt-300	HARROW, INC. (IMMY)
nPulse Cardiac Surgical Clamp (nsPFA Cardiac Surgery System)	Pulse Biosciences Inc Common Stock (DE) (PLSE)
Standard Care Arm	UNITED THERAPEUTICS Corp (UTHR)

Phase 2(2)

Drug	Company
melt-210	HARROW, INC. (IMMY)
stenoparib	Allarity Therapeutics, Inc. (ALLR)

Phase 1(3)

Drug	Company
hutrukin	XBiotech Inc. (XBIT)
hwk-016	Whitehawk Therapeutics, Inc. (WHWK)
Megadose Drug Combination	Cell Source, Inc. (CLCS)

Preclinical(1)

Drug	Company
mar-fg-001	MARIZYME, INC. (MRZM)

Unknown(16)

Drug	Company
Claria System	Organon & Co. (OGN)
Cord tissue service	Cryo-Cell International Inc. (CCEL)
Culpeo QCL-IR Liquid Analyzer	REPLIGEN CORP (RGEN)
Diagnostic Reagents Division OEM products (unnamed)	BIO-TECHNE Corp (TECH)
innovative production yield enhancement process	ADMA BIOLOGICS, INC. (ADMA)
Ketodex	COGNITION THERAPEUTICS INC (CGTX)
Ketofol	COGNITION THERAPEUTICS INC (CGTX)
KrosFlo RPM systems (with integrated FlowVPX technology)	REPLIGEN CORP (RGEN)
OPUS Pre-Packed Columns	REPLIGEN CORP (RGEN)
refisolone	Vistagen Therapeutics, Inc. (VTGN)
SIUS Gamma	REPLIGEN CORP (RGEN)
SoloVPE	REPLIGEN CORP (RGEN)
TangenX (SIUS, PRO, SC, SIUS Gamma)	REPLIGEN CORP (RGEN)
TangenX FS TFF cassettes	REPLIGEN CORP (RGEN)
TangenX SC Device	REPLIGEN CORP (RGEN)
XCell ATF	REPLIGEN CORP (RGEN)

BLA Filed(1)

Drug	Company
apollo revise	Apollo Endosurgery, Inc. (APEN)

BioSniper tracks 55 drugs in development for PROC across 34 companies.

There are 2 clinical trials targeting PROC tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.